More predictable results to deliver innovations sooner

We have more insight than ever before into multiple sclerosis (MS), Parkinson's disease, stroke, Alzheimer’s Disease, and other neurological disorders. But how do you make sense of this explosion of data and drill down to what matters most – for your indication and for the patients you work hard to serve?

As the leader in human data science, IQVIA is at the forefront of integrating human science expertise with advances in analytics and technology to help customers ask better questions, and extract more meaningful insights. With IQVIA, you can proactively create a more accurate picture of the patient pipeline, optimize study planning, and speed time to market.

  • Make the most of patient-level data and global site networks to hasten patient recruitment
  • Generate more predictable and precise trial results
  • Increase patient and provider awareness of key indicators, such as Alzheimer’s risk at the earliest stages of the disease.


IQVIA leverages data, advanced analytics and machine learning to identify Alzheimer’s patients in early stages and proactively support decisions across the patient journey. Produce more predictable results and deliver innovations to the neurology and Alzheimer’s medical community by leveraging IQVIA’s unique combination of data, machine learning and domain expertise.

Access broad and deep neurology expertise to help you reduce costs, accelerate timelines and manage risk.

Flexible solutions for Emerging Biopharma Companies
From defining the plan for your asset, to trial implementation, through launch and commercialization, IQVIA can help you find your path to success.